Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
The new normal
A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...
Reducing stroke risk in dementia patients
A commonly-used treatment for Alzheimer's disease could reduce the risk of stroke among people with dementia.
The Australian-Swedish study, co-authored by Monash University researchers, focussed...
Indirect impacts of COVID-19
Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.
Antioxidants and mineral supplements for slowing age-related macular degeneration
Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...
Choosing Wisely: new medicines advice service arrives
The Pharmaceutical Society of Australia (PSA) has released a list of recommendations for healthcare professionals to ensure the safe use of medicines.
The launch of...
